GENEELOU CRUZ: Open Payments
NPI 1093412033 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,819 in 113 payments from 19 companies in 2025. Trend: 2023 $946 · 2024 $1,659 · 2025 $1,819
Food & beverage: $1,719Education: $100
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 61 | $550 |
| Regeneron Healthcare Solutions, Inc. | 4 | $198 |
| Novartis Pharmaceuticals Corporation | 11 | $188 |
| SOBI, INC | 4 | $155 |
| Exelixis Inc. | 6 | $155 |
| BeOne Medicines USA, Inc. | 3 | $86 |
| ARRAY BIOPHARMA INC | 4 | $76 |
| AstraZeneca Pharmaceuticals LP | 3 | $70 |
| Incyte Corporation | 2 | $51 |
| Merck Sharp & Dohme LLC | 2 | $50 |
Products named: Enhertu, LIBTAYO, KISQALI, CABOMETYX, DATROWAY, BRUKINSA, LORBRENA, IMFINZI.
Industry payments across NV — which companies pay providers there.
